Implementation of practice guidelines.

G J Bosl; K F Malbin

Home/Archive/PubMed

PubMed · 9430177

Implementation of practice guidelines.

G J Bosl·K F Malbin

View original source ↗Export metadata ↓

Abstract

Memorial Sloan-Kettering Cancer Center staff, in conjunction with Cambridge Technology Partners, has designed, developed, and begun to implement a disease management system (DMS) as a means of standardizing the care of the center's patients with cancer. The disease management system is centrally coordinated through disease management teams, which include physicians from each of the major oncology disciplines--radiation, medicine, and surgery--as well as specialists and other professionals involved in patient care. The system is comprised of four modules: system administration, treatment pathways, patient management, and outcomes analysis. In July 1966, the gynecology team began to pilot this program, and the remaining 16 disease management teams were incorporated, in phases, during the rest of 1996. The regional sites are being incorporated in 1997. After a brief summary of the basic features of the disease management system, this article describes the implementation process and the accomplishments to date.

Explore related subjects

Databases, Factual Neoplasms Practice Guidelines as Topic Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

G J Bosl, K F Malbin. 1997. Implementation of practice guidelines.. https://pubmed.ncbi.nlm.nih.gov/9430177/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Performance of the FearID earprint identification system.

The Forensic Ear Identification (FearID) research project was started in order to study the strength of evidence of earprints found on crime scenes. For this purpose, a sample of earprints from 1229 donors over three countries was collected. From each donor three left and three right earprints were gathered. On the one hand, operators denoted contours of the earprints to facilitate segmentation of the images, on the other anthropological specialists denoted anatomically specific locations. On the basis of this, methods for automated classification were developed and used for training of a system that classifies pairs of prints as 'matching' or 'non-matching'. Comparing lab quality prints, the system has an equal error rate of 4%. Starting from a reference database containing two prints per ear, hitlist behaviour is such that in 90% of all query searches the best hit is in the top 0.1% of the list. The results become less favourable (equal error rate of 9%) for print/mark comparisons.

Databases, Factual↗

PubMed2006

Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events.

Post-marketing drug safety data sets are often massive, and entail problems with heterogeneity and selection bias. Nevertheless, quantitative methods have proven a very useful aid to help clinical experts in screening for previously unknown associations in these data sets. The WHO international drug safety database is the world's largest data set of its kind with over three million reports on suspected adverse drug reaction incidents. Since 1998, an exploratory data analysis method has been in routine use to screen for quantitative associations in this data set. This method was originally based on large sample approximations and limited to pairwise associations, but in this article we propose more accurate credibility interval estimates and extend the method to allow for the analysis of more complex quantitative associations. The accuracy of the proposed credibility intervals is evaluated through comparison to precise Monte Carlo simulations. In addition, we propose a Mantel-Haenszel-type adjustment to control for suspected confounders.

Databases, Factual↗

PubMed2006

Statistical methods and software for the analysis of highthroughput reverse genetic assays using flow cytometry readouts.

Highthroughput cell-based assays with flow cytometric readout provide a powerful technique for identifying components of biologic pathways and their interactors. Interpretation of these large datasets requires effective computational methods. We present a new approach that includes data pre-processing, visualization, quality assessment, and statistical inference. The software is freely available in the Bioconductor package prada. The method permits analysis of large screens to detect the effects of molecular interventions in cellular systems.

Databases, Factual↗